Loading clinical trials...
Loading clinical trials...
A Phase 1 Dose-Escalation and Repeated-Dose Study of the Safety and Tolerability of Intravitreal Pozelimab in Participants With Geographic Atrophy
Conditions
Interventions
Pozelimab
Locations
5
United States
Colorado Retina Associates
Lakewood, Colorado, United States
Ophthalmic Consultants of Boston
East Weymouth, Massachusetts, United States
Austin Retina Associates
Austin, Texas, United States
Retina Foundation of the Southwest
Dallas, Texas, United States
Retina Consultants Texas
The Woodlands, Texas, United States
Start Date
January 19, 2026
Primary Completion Date
July 3, 2028
Completion Date
July 3, 2028
Last Updated
April 24, 2026
Lead Sponsor
Regeneron Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions